Dissemin is shutting down on January 1st, 2025

Published in

MDPI, Fractal and Fractional, 2(7), p. 192, 2023

DOI: 10.3390/fractalfract7020192

Links

Tools

Export citation

Search in Google Scholar

Deterministic and Fractional-Order Co-Infection Model of Omicron and Delta Variants of Asymptomatic SARS-CoV-2 Carriers

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

The Delta and Omicron variants’ system was used in this research study to replicate the complex process of the SARS-CoV-2 outbreak. The generalised fractional system was designed and rigorously analysed in order to gain a comprehensive understanding of the transmission dynamics of both variants. The proposed dynamical system has heredity and memory effects, which greatly improved our ability to perceive the disease propagation dynamics. The non-singular Atangana–Baleanu fractional operator was used to forecast the current pandemic in order to meet this challenge. The Picard recursions approach can be used to ensure that the designed fractional system has at least one solution occupying the growth condition and memory function regardless of the initial conditions. The Hyers–Ulam–Rassias stability criteria were used to carry out the stability analysis of the fractional governing system of equations, and the fixed-point theory ensured the uniqueness of the solution. Additionally, the model exhibited global asymptotically stable behaviour in some conditions. The approximate behaviour of the fatal virus was investigated using an efficient and reliable fractional numerical Adams–Bashforth approach. The outcome demonstrated that there will be a significant decline in the population of those infected with the Omicron and Delta SARS-CoV-2 variants if the vaccination rate is increased (in both the symptomatic and symptomatic stages).